Valeant Completes Acquisition Of Synergetics USA, Inc.
Tuesday, October 20 2015 | 00 h 00 min | Acquisitions, Press Release
LAVAL, Quebec- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) announced that it has completed the previously announced acquisition of Synergetics USA, Inc. (“Synergetics”). Synergetics is a leading supplier of precision surgical devices. Synergetics’ primary focus is on the surgical disciplines of ophthalmology and neurosurgery.